##
|||Page||
|---|---|---|---|
|Report ofthe Trustees|I|to|4|
|Report ofthe Independent
Auditors|5|to|8|
|Statement ofFinancial Activities||||
|Balance Sheet||10||
|Notes to the Financial Statements|11|to|17|
|Detailed Statement ofFinancial Activities|18|to|19|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||||30.9.21|30.9.20|
|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Total|Total|
|||||fund|fund|funds|funds|
||||Notes|||||
|INCOME AND ENDOWMENTS FROM||||||||
|Donations
and legacies||||19,557|27,946|47,503|18,884|
|Charitable
activities||||||||
|Research into and education||on oncology|||28,528|28,528|37,584|
|Investment
income|||2|9,179|36,771|45,950|40,188|
|Other income|||||1300|1380|140D|
|Total||||28,736|94,625|123,361|98,056|
|EXPENDITURE ON||||||||
|Raising funds|||3|3,600|14,452|18,052|13,339|
|Charitable
activities||||||||
|Research into and education||on oncology||12,411|54,497|66,908|82,412|
|Total||||16,011|68,949|84,960|95,751|
|Net gains/(losses)
on|investments|||~25969|1D4,251|130226|~120062|
|NET INCOME/(EXPENDITURE)||||38,694|129,933|168,627|(116,557)|
|RECONCILIATION|OF FUNDS|||||||
|Total funds brought|forward|||279,437|1,121,867|1,401,304|1,517,861|
|TOTAL FUNDS CARRIED FORWARD||||310,131|1251 800|1569,931|I 401 3D4|
|||||30.9.21|30.9.20|
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
||Notes|fund
f|fund|funds|funds|
|FIXEDASSETS||||||
|Investments|11|175,566|1,093,704|1,269,270|1,112,186|
|CURRENT ASSETS||||||
|Debtors
Cash at bank|12|2,593
~150352|17,534
161,698|20,127
~312050|15,985
284,280|
|||152,945|179,232|332,177|300,265|
|CREDITORS||||||
|Amounts
falling due within one year|13|(10,380)|(21,136)|(31,516)|(11,147)|
|NET CURRENT ASSETS||142,565|158,096|300,661|289,118|
|TOTAL ASSETSLESSCURRENT||||||
|LIABILITIES||318,131|1,251,800|1,569,931|1,401,304|
|NET ASSETS||~325 131|1 251,SDD|1569 932|1,401,304|
|FUNDS|14|||||
|Unrestricted
funds
Restricted
funds||||318,131
1,251,800|279,437
1,121,867|
|TOTAL FUNDS||||1,569,931|1,401,304|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Short term trade creditors|are measured|at the transaction|at the transaction|price. Other financial|liabilities,
including|liabilities,
including|bank loans,|
|---|---|---|---|---|---|---|---|
|are measured
initially
at|fair value, net|of transaction|costs, and are measured||subsequently|at amortised
cost||
|using the effective interest|method.|||||||
|INVESTMENT INCOME||||||||
||||||30.9.21
f||30.9.20
f|
|Other investment
income|||||45,914||39,774|
|Deposit account interest|||||36||414|
||||||45,950||40,188|
|RAISING FUNDS||||||||
|Investment
management|costs|||||||
||||||30.9.21
f||30.9.20
f|
|Portfolio management|||||18,052||13,339|
##
##
|||||||Governance||
|---|---|---|---|---|---|---|---|
||||||Other|costs|Totals|
||||||f|f||
|Research|into and education||on oncology||~9246|~4800|14,046|
|NET INCOME/(EXPENDITURE)||||||||
|Net income/(expenditure)||is|stated atter charging/(crediting):|||||
|||||||30.9.21|30.9.20|
|Auditors'|remuneration|||||3,600|3,600|
|Auditors'|remuneration|for non-audit||work||~1200|1,200|
##
##
##
||||30.9.21|30.9.20|
|---|---|---|---|---|
||||f||
|Wages|and|salaries|45,667|54,459|
||||45,667|54,459|
|Staffcosts are solely|made up ofwages recharged|made up ofwages recharged|t'rom various|trusts during the year.||
|---|---|---|---|---|---|
|The average monthly|number ofemployees|during|the year was|as follows:||
|Research staff||||30.9.21
2|30.9.20
=2|
##
|During the year an ex-grati
for the work undertaken
in|a payment ofI3,000 was made to the volunteer
bookke
managing
the charities accounting
function.|a payment ofI3,000 was made to the volunteer
bookke
managing
the charities accounting
function.|eper for the c|harity as thanks|
|---|---|---|---|---|
|COMPARATIVES FOR|THE STATEMENT OFFINANCIAL ACTIVITIES||||
|||Unrestricted|Restricted|Total|
|||fund|fund|funds|
|||8|||
|INCOME AND ENDOWMENTS FROM|||||
|Donations
and legacies||7,529|11,355|18,884|
|Charitable
activities|||||
|Research into and education|on oncology||37,584|37,584|
|investment
income||8,064|32,124|40,188|
|Other income|||1,400|1,400|
|Total||15,593|82,463|98,056|
|EXPENDITURE ON|||||
|Raising funds||2,658|10,681|13,339|
|Charitable
activities|||||
|Research into and education|on oncology|12,273|70,139|82,412|
|Total||14,931|80,820|95,751|
|Net gains/(losses)
on investments||~23,686|~96.)36)|~))8,862)|
|NET INCOME/(EXPENDITURE)||(23,024)|(93,533)|(116,557)|
|RECONCILIATION
OFFUNDS|||||
|Total funds brought forward||302,461|1,215,400|1,517,861|
|TOTAL FUNDS CARRIED FORWARD||279,437|1,121,867|1 401,304|
##
##
|||Listed|
|---|---|---|
|||investments|
|MARKET VALUE|||
|At 1 October 2020||1,112,186|
|Additions||508,074|
|Disposals||(450384)|
|Revaluations||99,394|
|At 30September 2021||1,269,270|
|NET BOOK VALUE|||
|At 30September 2021||1,269,270|
|At 30 September 2020||1,112,186|
|There were no investment|assets outside the UK.||
##
|||||Listed|
|---|---|---|---|---|
|||||investments|
|Valuation|in|2021||99,394|
|Cost||||1169976|
|||||1269276|
|DEBTORS:||AMOUNTS FALLING DUK WITHIN ONE YEAR|||
||||30.9.21|30.9.20|
||||g|I|
|Other debtors|||13,192|3,153|
|Prepayments||and accrued income|~6935|12,832|
||||20,127|15,985|
|13.|CREDITORS:|CREDITORS:|AMOUNTS FALLING DUE WITHIN ONE YEAR|AMOUNTS FALLING DUE WITHIN ONE YEAR|AMOUNTS FALLING DUE WITHIN ONE YEAR|AMOUNTS FALLING DUE WITHIN ONE YEAR|AMOUNTS FALLING DUE WITHIN ONE YEAR|AMOUNTS FALLING DUE WITHIN ONE YEAR|AMOUNTS FALLING DUE WITHIN ONE YEAR||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||||30.9.21||||30.9.20|
|||||||||||||||||f|
||Trade creditors||||||||||||23,716|||410|
||Accrued expenses||||||||||||~7000|||~10 737|
||||||||||||||31,516|||11,147|
|14.|MOVEMENT|IN FUNDS|||||||||||||||
||The restricted|funds below, are funds||||held by the Trust on behalf ofConsultants||||||and applied|||for|their research|
||projects. When||funds|are received|for a specific consultant,||||they are|allocated||the|relevant||Consultants
fund||
||under Restricted||Funds. Any other||funds,
non-specific,
are allocated|||||to the|General|||fund,|under|Unrestricted|
||Funds.||||||||||||||||
||The Development||fund|is a grant based fund to cover general|||||administration||expenses|||and|staff|development.|
||Cyberknife
and||Head|and Neck Funds
are restricted||||for specific treatments|||and|can||be used by named
fund|||
||holders.||||||||||||||||
|||||At|incondng|||Resources|Gains|||Trsnslers|||||
||||01.10.20
f||Resources|||expended
f|nnd
losses
5|||betweea
fundsf||||At
30.09.21
5|
||Unrestricted
funds||||||||||||||||
||General
Breast|||118,794
46,516|16,454
1,524|||(13471)
(1,249)|11,040
4,323|||||||133,017
51,114|
||Development
Fightiug Breast|||85,979||2,817||(1,108)||7,990||||||95,678|
||Cancer|||28,148||7 41||383||2,616||||||38,322|
|||||279,437||28,736||(16,011)|25,969|||||||318,131|
||Restricted funds||||||||||||||||
||FrofP Hoskin
Dr AMskris
Dr P Ostler
Dr C Lemon/ Dr K|||527417
91,454
25,287||55,650
2,997
829||(44,728)
(2,259)
(326)||48,995
8,499
2,350||||||587,134
100,69i
28,140|
||Chiu
Dr M Harrison
Dr N Shah
Dr D Miles
Dr SMewdsley
Dr RAlonzi
Development
Cyberkoife
Fund
Dr Westbuiy|||176/68
18,540
65,279
96,678
13,665
20,550
68,170
8,944||22,875
607
2,139
3,418
448
1,051
2/34
515||(15Z58)
(239)
(841)
(3,473)
(176)
(298)
(878)
(351)||16,409
1,723
6,067
8/84
t/70
tg10
6,335
831||||||200,594
20,631
72,644
105,607
15,207
23,213
75,861
9s)39|
||/Guppy
Dr Neel Bhuvs
Brschy|||6,071
3,444||199
2463
300||(78)
(44)||564
320||||||6,756
5,083
300|
||||~1121,867|||94,625|~68,949)||~104257|||||||tZ51,800|
##
##
|TOTAL|FUNDS||||||||
|---|---|---|---|---|---|---|---|---|
|||~1401304|123361|~04|960)|~130226|-|~1569Tt31|
##
|Detailed Statement ofFinancial Activities|Detailed Statement ofFinancial Activities|||
|---|---|---|---|
|for the Year Ended 30Se|tember 2021|||
|||30.9.21|30.9.20|
|INCOME AND ENDOWMENTS||||
|Donations
and legacies||||
|Donations||30,180|17,884|
|Legacies||~17 323|1 000|
|||47,503|18,884|
|Investment
income||||
|Other investment
income||45,914|39,774|
|Deposit account interest||36|414|
|||45,950|40,188|
|Charitable
activities||||
|Grants||28,528|37,584|
|Other income||||
|Training
income||1,080|1,400|
|Other income||300||
|||1
80|1,400|
|Total incoming resources||123,361|98,056|
|EXPENDITURE||||
|Investment
management|costs|||
|Portfolio management||18,052|13,339|
|Charitable
activities||||
|Research salaries||45,667|54,459|
|Research materials||4,919|1,705|
|Transport
expenses|||90|
|Lecture fees|||(110)|
|Conference||1,996|6,527|
|Computer
expenses||280|4,412|
|||52,862|67,083|
|Support costs||||
|Other||||
|Subscriptions||1,432|1,526|
|Administrative
expenses||7,576|8,288|
|Travelling||238|715|
|||9,246|10,529|
|for the Year Ended 30 S|e tember 202|1|||
|---|---|---|---|---|
||||30.9.21|30.9.20|
|Other|||||
|Governance
costs|||||
|Auditors'
remuneration
Auditors'
remuneration|for non-audit|work|3,600
~1200|3,600
1200|
||||~4800|4,800|
|Total resources expended|||~84 960|95,751|
|Net income before gains|and losses||38,401|2,305|
|Realised recognised
gains and losses|||||
|Realised gains/(losses)
on fixed asset||investments|24,858|f28,659)|
|Net income/(expenditure)|||63,259|~26,354)|